A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects

Psychiatry Research

Volumn 97, Issue 1, 2000, Pages 21-28

  Scott, Lucinda V ^a   Svec, Frank ^b   Dinan, Timothy ^c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Adrenocorticotropin (ACTH); Chronic fatigue syndrome (CFS); Cortisol; Dehydroepiandrosterone (DHEA)

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; PRASTERONE; TETRACOSACTIDE;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; PREDICTIVE VALUE OF TESTS;

EID: 0034606463     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(00)00219-5     Document Type: Article

References (32)

1. Dehydroepiandrosterone treatment of midlife dysthymia
2. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
3. A possible role for cortisol/anticortisols in the progression of human immunodeficiency virus
4. Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects
5. Dehydroepiandrosterone response to I.V. ACTH in patients with chronic fatigue syndrome
6. Insulin-like growth factor (IGF-1) and dehydroepiandrosterone sulfate in obese women
7. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome
8. Adrenocorticotropin-stimulation test: effects of basal cortisol levels, time of day and suggested new sensitive low dose test
9. Serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome
10. Physiological importance of dehydroepiandrosterone
11. A randomised controlled trial of graded exercise in chronic fatigue syndrome
12. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group
13. Adrenal secretion during major depression in 10-16 year olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation
14. Increased diurnal concentrations of plasma dehydroepiandrosterone in depressed patients
15. Dehydroepiandrosterone, dehydroepiandrosterone-sulfate and cardiovascular disease
16. The metabolism of dehydroepiandrosterone sulfate
17. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
18. Serum dehydroepiandrosterone-sulfate in Alzheimer's disease and in multi-infarct dememtia
19. The corticotropin-releasing factor hypothesis of depression: new findings and new directions
20. The secretion of DHA and DHAS in man
21. Long term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal man
22. Adrenal androgens and cortisol in major depression
23. Evidence for adrenocortical adaptation to severe stress
24. Urinary cortisol excretion in chronic fatigue syndrome, in depression and in health
25. The low-dose adrenocorticotropin test in chronic fatigue syndrome and in health
26. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health
27. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study
28. The relationship of serum DHEA-S and cortisol to measures of immune function in human immuno-deficiency virus-related illnesses
29. Plasma corticotropin-releasing factor and vasopressin responses to exercise in normal man
30. Antiglucocorticoid action of dehydroepiandrosterone in young, obese Zucker rats